XWAR
IMP
Market cap3mUSD
Jul 10, Last price
1.50PLN
1D
0.00%
1Q
0.00%
Jan 2017
16.28%
Name
Imperio Alternatywna Spolka Inwestycyjna SA
Chart & Performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Imperio Alternatywna Spolka Inwestycyjna S.A., founded in 1995 and headquartered in Warsaw, Poland, operates as a private equity and venture capital firm. The company targets a broad spectrum of ventures, from nascent seed and early-stage startups to established mature businesses, as well as those undergoing expansion, preparing for an IPO, or requiring restructuring. It also backs firms seeking to expand or diversify their core operations. Its investment portfolio spans high-growth sectors such as e-commerce, biotechnology, life sciences, renewable/clean technology, energy, information and communication technology (ICT), media, telecommunications, the Internet, modern services, and innovative production technologies. The firm's primary geographical focus is Poland. Imperio's typical investment in portfolio companies ranges from PLN 4 million to PLN 15 million (approximately $0.4 million to $5.04 million), though larger commitments are possible. The company generally acquires a significant equity interest, often exceeding 35%. While it often seeks a majority stake in early-stage ventures, its involvement in pre-IPO or restructuring projects typically entails a smaller holding, usually 10% to 15%. Imperio frequently co-invests alongside other financial institutions, particularly venture capital funds, and can utilize hybrid financing structures like convertible bonds or provide direct loans. Investment horizons typically range from four to six years for early-stage ventures and three to five years for more mature projects. Potential exit strategies include mergers, buyouts by management or co-owners, sales to strategic or trade investors, or public market listings.
Valuation
Title PLN in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||